Our Research

Research

At Houston Methodist, fostering innovations with the potential for clinical application is at the very heart of what we do. Our interdisciplinary teams of clinicians and researchers are committed to streamlining the process of translating discoveries into treatments and cures for our patients.

 

Learn more about how we are delivering on our commitment to leading medicine from the earliest phase of discovery in a lab to the testing new drugs or therapies in clinical trials.

 

Our Annual Report



Neuroscientists find molecular clue in als suggesting potential new drug target

Houston Methodist researchers led by Muralidhar Hegde, PhD, and Haibo Wang, PhD, have discovered a repair defect in nerve cells that send messages to the brain, opening the door to a possible therapy for preventing or slowing down ALS. Learn more>

 

Scientists create Nanodevice to deliver immunotherapy without side effects

Houston Methodist scientists led by Alessandro Grattoni, PhD, have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. Learn More>

 

RNA Therapy Reverses Effects of Aging in Progeria Cells
Cooke Feature Image

Houston Methodist scientists led by John Cooke, MD, PhD used telomerase mRNA technology to reverse senescence, rejuvenating aging human cells. Learn more.

Protein Protecting T-cells Aids in Destruction of Liver Immune Cells
Liver Feature Image

A Houston Methodist research team led by Xian Li, MD, PhD, identified the surface protein OX40 as a mediator of liver inflammation and disease. Learn more.

Latest News
Thursday, December 6, 2018 Houston Methodist launches real-time flu tracker website
Pathologists at Houston Methodist developed a real-time website to track flu cases, just in time to assist physicians, the CDC and patients for the fall 2018 flu season.   The up-to-date information on flu.houstonmethodist.org contains flu epidemiology data covering Houston Methodist’s eight-hospita...
Read more